• wonderlic tests
  • EXAM REVIEW
  • NCCCO Examination
  • Summary
  • Class notes
  • QUESTIONS & ANSWERS
  • NCLEX EXAM
  • Exam (elaborations)
  • Study guide
  • Latest nclex materials
  • HESI EXAMS
  • EXAMS AND CERTIFICATIONS
  • HESI ENTRANCE EXAM
  • ATI EXAM
  • NR AND NUR Exams
  • Gizmos
  • PORTAGE LEARNING
  • Ihuman Case Study
  • LETRS
  • NURS EXAM
  • NSG Exam
  • Testbanks
  • Vsim
  • Latest WGU
  • AQA PAPERS AND MARK SCHEME
  • DMV
  • WGU EXAM
  • exam bundles
  • Study Material
  • Study Notes
  • Test Prep

BIOD 210 Module 8 GENETICS Human Cancers Latest Review Exam Q & A 2026 (Complete And Verified Study material) (18pages) LEARNEXAMS

exam bundles Jan 26, 2024
Preview Mode - Purchase to view full document
Loading...

Loading study material viewer...

Page 0 of 0

Document Text

1. What is the role of oncogenes in cancer development? - A) Suppress tumor formation - B) Repair DNA - C) Promote cell division - D) Enhance immune response Answer: C) Promote cell division Rationale: Oncogenes are genes that, when mutated or expressed at high levels, can transform a normal cell into a cancerous one by promoting uncontrolled cell division. 2. Which genetic syndrome is associated with a high risk of developing breast and ovarian cancer? - A) Down syndrome - B) Turner syndrome - C) Lynch syndrome - D) BRCA1/2 mutations Answer: D) BRCA1/2 mutations Rationale: Mutations in BRCA1 and BRCA2 genes significantly increase the risk of breast and ovarian cancer. 3. How does the p53 gene contribute to tumor suppression? - A) By promoting angiogenesis - B) By inducing apoptosis in damaged cells - C) By activating oncogenes - D) By increasing mutation rates Answer: B) By inducing apoptosis in damaged cells Rationale: The p53 gene produces a protein that can stop the cell cycle, allowing for DNA repair or inducing apoptosis if the damage is irreparable, thus acting as a tumor suppressor. 4. What is the significance of the Philadelphia chromosome in chronic myelogenous leukemia (CML)? - A) It confirms a diagnosis of CML - B) It is a result of translocation between chromosomes 9 and 22 - C) It indicates a poor prognosis - D) It is a protective factor against CML Answer: B) It is a result of translocation between chromosomes 9 and 22


Download Study Material

Buy This Study Material

$20.00
Buy Now
  • Immediate download after payment
  • Available in the pdf format
  • 100% satisfaction guarantee

Study Material Information

Category: exam bundles
Description:

BIOD 210 Module 8 GENETICS Human Cancers Latest Review Exam Q & A 2026 (Complete And Verified Study material) (18pages) LEARNEXAMS

UNLOCK ACCESS $20.00